Injection Pen Market to Reach $74.1 Billion by 2030

Got story updates? Submit your updates here. ›

The global injection pen market is projected to reach USD 74.1 billion by 2030, growing at a CAGR of 7.9% during the forecast period. The market is driven by the rising demand for self-administration devices, particularly in the treatment of chronic diseases like diabetes, obesity, and osteoporosis.

Why it matters

The growth of the injection pen market is significant as it reflects the increasing preference for self-administration devices, which can improve patient convenience, adherence, and overall healthcare outcomes. The market expansion is also driven by the growing burden of chronic diseases, an aging population, and government initiatives to improve affordability and accessibility of these devices.

The details

The injection pen market is segmented by type (disposable and reusable pens), therapy (diabetes, growth hormone, osteoporosis, obesity, fertility), and end-user (homecare and hospitals & clinics). The disposable injection pens segment held the largest market share in 2023. The homecare settings segment led the market, capturing the largest share and growing at a faster pace. Geographically, the North American market is expected to witness significant growth.

• The injection pen market is projected to reach USD 74.1 billion by 2030.
• The market is expected to grow at a CAGR of 7.9% during the forecast period from 2024 to 2030.

What’s next

The report provides a comprehensive analysis of the injection pen market, including key players, market trends, and growth opportunities. As the market continues to evolve, further research and analysis will be needed to understand the long-term implications and potential impact on the healthcare industry.